Promoting global health: utilizing WHO to integrate public health, innovation and intellectual property.
نویسندگان
چکیده
The appropriate role of innovation and intellectual property (IP) in global public health is a controversial issue. Discussion is one-sided, with potential benefits advocated by industry in stark contrast to condemnation by certain civil society players. WHO's Public Health, Innovation and Intellectual Property Department (PHI) was established to address healthcare resource need for developing countries, assess impact of innovation and IP on access to medicines, explore innovative funding mechanisms for R&D and provide evidence-based policy-making recommendations in response to the changing global health landscape. Importantly, PHI could represent a potential forum to bridge shared, yet often diverse, interests and opportunities between various public and private stakeholders, a crucial issue for ensuring the future viability of WHO.
منابع مشابه
WHO Intergovernmental Working Group on public health, innovation and intellectual property.
The inaccessibility of medicines in lowand middle-income countries poses serious human rights and developmental challenges for Governments and international organizations, as well as raising grave ethical and human rights questions about the responsibilities of the research and development-based pharmaceutical industry. In response to this human rights and public-health dilemma, there has been ...
متن کاملSri Lanka's national assessment on innovation and intellectual property for access to medical products.
In 2008, the Global strategy and plan of action on public health, innovation and intellectual property (GSPA-PHI) was launched by the World Health Organization, to stimulate fresh thinking on innovation in, and access to, medicines and to build sustainable research on diseases disproportionately affecting low- and middle-income countries. As part of the activities of the GSPA-PHI, Sri Lanka has...
متن کاملReport of the Commission on Intellectual Property Rights, Innovation and Public Health: an industry perspective.
The report issued by WHO’s Commission on Intellectual Property, Innovation, and Public Health1 (CIPIH) makes a number of positive recommendations for improving health in developing countries. However, the report understates the value of intellectual property rights for promoting public health and overstates the importance of intellectual property in affecting access to health care. Indeed, the ...
متن کاملPolicy coherence for improved medical innovation and access.
Editorials 315 Public policy-making is an increasingly complex undertaking in a globalizing world, especially as policy domains formerly viewed in isolation become more intertwined. This complexity marks the interplay between health, intellectual property and trade policies. Can such interplay be managed so as to enhance the discovery, development and delivery of medical technologies for better...
متن کاملPharmaceutical arbitrage: balancing access and innovation in international prescription drug markets.
Expensive prescription drugs lie at the heart of two major public health issues: the global AIDS epidemic; and US patients obtaining less expensive drugs from Canada over the internet. Both situations call for reducing financial barriers to innovative drugs while maintaining incentives to promote innovation. For better or for worse, the WTO TRIPS Agreement on intellectual property (IP) is the g...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Drug discovery today
دوره 17 23-24 شماره
صفحات -
تاریخ انتشار 2012